Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, Brazil.
Dental Oncology Service, Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.
Oral Dis. 2022 Nov;28 Suppl 2:2391-2399. doi: 10.1111/odi.13876. Epub 2021 May 7.
To evaluate whether the coronavirus disease 2019 has increased anxiety, depression, and distress levels in head and neck cancer (HNC) patients undergoing radiotherapy (RT).
In this cross-sectional study, RT-HNC patients were surveyed using the Hospital Anxiety and Depression Scale (HADS) for anxiety and depression and the distress thermometer (DT) for distress. HADS scores were compared with data pre-COVID-19. Additionally, we evaluated the COVID-19 impact on daily routines, treatment, and cancer care through a questionnaire.
Fifty patients were included. The HADS mean score and estimated rates were 4.34 (±4.06)/22% for anxiety and 5.08 (±4.82)/22% for depression; in comparison, our historical control had 4.04 (±3.59)/20% for anxiety (p = .79) and 4.03 (±3.62)/17% for depression (p = .49). Mean DT score was 3.68 (±2.77). Responders were aware of COVID-19, afraid of having medical complications, believed it was life-threatening, did not miss appointments, believed their treatment was not impacted, and felt safe at the hospital amid the pandemic.
This study suggests that anxiety, depression, and distress levels found in RT-HNC patients did not increase during the pandemic. Patients were afraid of being infected by COVID-19; however, they complied with their cancer treatment.
评估 2019 年冠状病毒病（COVID-19）是否会增加接受放射治疗（RT）的头颈部癌症（HNC）患者的焦虑、抑郁和痛苦水平。
在这项横断面研究中，使用医院焦虑和抑郁量表（HADS）评估 RT-HNC 患者的焦虑和抑郁，使用痛苦温度计（DT）评估痛苦。将 HADS 评分与 COVID-19 前的数据进行比较。此外，我们通过问卷评估 COVID-19 对日常生活、治疗和癌症护理的影响。
共纳入 50 例患者。HADS 平均得分为 4.34（±4.06）/22%，抑郁得分为 5.08（±4.82）/22%；相比之下，我们的历史对照组焦虑得分为 4.04（±3.59）/20%（p=0.79），抑郁得分为 4.03（±3.62）/17%（p=0.49）。平均 DT 得分为 3.68（±2.77）。有反应者了解 COVID-19，害怕出现医疗并发症，认为 COVID-19 有生命危险，没有错过预约，认为他们的治疗不受影响，并且在大流行期间在医院感到安全。
本研究表明，接受 RT 的 HNC 患者的焦虑、抑郁和痛苦水平在大流行期间没有增加。患者害怕感染 COVID-19，但他们仍坚持接受癌症治疗。
